• Generic Name
• Item
• Area
• Certification
• Note
• Structuer
• APi
• 询价

• 马西腾坦
• 原料药和医药中间体
• Pulmonary Arterial Hypertension (PAH)

• USA

  -USDMF No. 031658

  Eu/ASMF 6 countries

  China

  -CDE Registration No.:Y20190000010

  WC to EU:ZJ240108
• 5 years stability
• 询价

• 马西腾坦预混颗粒
• 原料药和医药中间体
• Pulmonary Arterial Hypertension (PAH)
• non-infringing formulation
• 询价

• 司来帕格
• 原料药和医药中间体
• Pulmonary arterial hypertension

• USA

  -ANDA No. 211026

  Tentative Approval

  China

  -CYHS1900599 Launched

  COPP:ZJ240108
• US DMF ready
• 询价

• 司来帕格中间体
• 原料药和医药中间体
• Pulmonary arterial hypertension
• Patented process(CN10482965B, US10144701B2, US10428012B2,cn106279047B, U10040771B2 )
• 询价

• 司来帕格预混颗粒
• 原料药和医药中间体
• Pulmonary arterial hypertension
• Ready for PV
• non-infringing polymorphism
• 询价

• 利伐沙班中间体
• 原料药和医药中间体
• Anti-Thrombosis
• Commercial
• patented process
• 询价

• 利伐沙班中间体
• 原料药和医药中间体
• Anti-Thrombosis
• Commercial
• patented process
• 询价

• 沃替西汀
• 原料药和医药中间体
• Antidepressant

• USA

  -USDMF No. 038847

  China-CDE Registration No.:Y20230001182

• 4 years stability
• 询价

• 沃替西汀中间体
• 原料药和医药中间体
• Antidepressant
• GC >99%
• 询价

• 沃替西汀预混颗粒
• 原料药和医药中间体
• Antidepressant
• PV done
• non-infringing polymorphism
• 询价

• 司美格鲁肽中间体
• 原料药和医药中间体
• Antidiabetic, weight reducing, hypotensive
• HPLC >98%, 10Kg/batch, 1000kg/year
• 询价

• 4-Chlorophenethylamine
• 询价